Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
European Journal of Clinical Pharmacology|April 6, 2011
Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysisRafael Dal-RéExpert Review of Clinical Pharmacology|August 16, 2020
Ongoing non-industry-sponsored COVID-19 clinical trials in the first trimester of the pandemic: significant differences between the European and the USA approachesRafael Dal-RéEuropean Journal of Clinical Pharmacology|May 25, 2020
Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 toolRafael Dal-RéEnfermedades Infecciosas Y Microbiologia Clinica|July 15, 2015
[Is it ethically acceptable to invite a pregnant woman to enroll in a clinical trial with Tdap if it could entail not being vaccinated with Tdap before delivery?]Rafael Dal-RéMedicina Clinica|June 27, 2019
Analysis of biomedical Spanish articles retracted between 1970 and 2018Rafael Dal-RéJournal of Evaluation in Clinical Practice|July 8, 2017
Could phase 3 medicine trials be tagged as pragmatic? A case study: The Salford COPD trialRafael Dal-RéHealth Education & Behavior : the Official Publication of the Society for Public Health Education|May 12, 2011
Worldwide behavioral research on major global causes of mortalityRafael Dal-RéEuropean Journal of Clinical Pharmacology|October 27, 2020
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trialsRafael Dal-RéExpert Review of Clinical Pharmacology|February 20, 2020
Participants' written informed consent in low-risk pragmatic clinical trials with medicinesRafael Dal-RéTherapie|July 30, 2022
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humansRafael Dal-RéPageof 9